155 related articles for article (PubMed ID: 32669717)
21. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.
del Monte F; Williams E; Lebeche D; Schmidt U; Rosenzweig A; Gwathmey JK; Lewandowski ED; Hajjar RJ
Circulation; 2001 Sep; 104(12):1424-9. PubMed ID: 11560860
[TBL] [Abstract][Full Text] [Related]
22. Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.
Samuel TJ; Rosenberry RP; Lee S; Pan Z
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621141
[TBL] [Abstract][Full Text] [Related]
23. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.
Heerdt PM; Holmes JW; Cai B; Barbone A; Madigan JD; Reiken S; Lee DL; Oz MC; Marks AR; Burkhoff D
Circulation; 2000 Nov; 102(22):2713-9. PubMed ID: 11094037
[TBL] [Abstract][Full Text] [Related]
24. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
[TBL] [Abstract][Full Text] [Related]
25. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
Kawase Y; Ly HQ; Prunier F; Lebeche D; Shi Y; Jin H; Hadri L; Yoneyama R; Hoshino K; Takewa Y; Sakata S; Peluso R; Zsebo K; Gwathmey JK; Tardif JC; Tanguay JF; Hajjar RJ
J Am Coll Cardiol; 2008 Mar; 51(11):1112-9. PubMed ID: 18342232
[TBL] [Abstract][Full Text] [Related]
26. [Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure].
Fu ZQ; Li XY; Liu XH; Sun S; Liu T; Mi YF; Zhou SA; Ye WH; Wang QS
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):260-5. PubMed ID: 19099986
[TBL] [Abstract][Full Text] [Related]
27. Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
Heerdt PM; Klotz S; Burkhoff D
Anesth Analg; 2006 Jan; 102(1):32-7. PubMed ID: 16368801
[TBL] [Abstract][Full Text] [Related]
28. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Papolos A; Frishman WH
Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
[TBL] [Abstract][Full Text] [Related]
29. AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.
Bisserier M; Milara J; Abdeldjebbar Y; Gubara S; Jones C; Bueno-Beti C; Chepurko E; Kohlbrenner E; Katz MG; Tarzami S; Cortijo J; Leopold J; Hajjar RJ; Sassi Y; Hadri L
Mol Ther; 2020 Feb; 28(2):394-410. PubMed ID: 31879190
[TBL] [Abstract][Full Text] [Related]
30. Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.
Lipskaia L; Hadri L; Lopez JJ; Hajjar RJ; Bobe R
Curr Vasc Pharmacol; 2013 Jul; 11(4):465-79. PubMed ID: 23905641
[TBL] [Abstract][Full Text] [Related]
31. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
Wasala NB; Yue Y; Lostal W; Wasala LP; Niranjan N; Hajjar RJ; Babu GJ; Duan D
Mol Ther; 2020 Mar; 28(3):845-854. PubMed ID: 31981493
[TBL] [Abstract][Full Text] [Related]
32. Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.
Mattila M; Koskenvuo J; Söderström M; Eerola K; Savontaus M
J Gene Med; 2016 Jul; 18(7):124-33. PubMed ID: 27203155
[TBL] [Abstract][Full Text] [Related]
33. [Gene therapy in heart failure: the unexpected results from the CUPID 2 trial].
Gigli M; Sinagra G; Mestroni L
G Ital Cardiol (Rome); 2017 Feb; 18(2):101-105. PubMed ID: 28398363
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
Li XY; Hui HP; Lu XC; Guo YT
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression.
Zhu X; McTiernan CF; Rajagopalan N; Shah H; Fischer D; Toyoda Y; Letts D; Bortinger J; Gibson G; Xiang W; McCurry K; Mathier M; Glorioso JC; London B
Hum Gene Ther; 2012 Jul; 23(7):722-32. PubMed ID: 22482463
[TBL] [Abstract][Full Text] [Related]
36. Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart.
Ogletree ML; Sweet WE; Talerico C; Klecka ME; Young JB; Smedira NG; Starling RC; Moravec CS
J Heart Lung Transplant; 2010 May; 29(5):554-61. PubMed ID: 20044278
[TBL] [Abstract][Full Text] [Related]
37. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
[TBL] [Abstract][Full Text] [Related]
38. Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia.
Xin W; Li X; Lu X; Niu K; Cai J
Acta Cardiol; 2011 Feb; 66(1):57-64. PubMed ID: 21446381
[TBL] [Abstract][Full Text] [Related]
39. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins.
Sakata S; Lebeche D; Sakata N; Sakata Y; Chemaly ER; Liang LF; Tsuji T; Takewa Y; del Monte F; Peluso R; Zsebo K; Jeong D; Park WJ; Kawase Y; Hajjar RJ
J Mol Cell Cardiol; 2007 Apr; 42(4):852-61. PubMed ID: 17300800
[TBL] [Abstract][Full Text] [Related]
40. Cardiac SERCA2A/B: therapeutic targets for heart failure.
Shareef MA; Anwer LA; Poizat C
Eur J Pharmacol; 2014 Feb; 724():1-8. PubMed ID: 24361307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
